Western Blot: RAB3IP Antibody [H00117177-B01P] - Analysis of RAB3IP expression in rat brain.
Chromatin Immunoprecipitation: RAB3IP Antibody [H00117177-B01P] - 5dpf neuromast immunostained for Rab3IP (red) and counterstained with phalloidin (green). Image courtesy of customer.
Western Blot: RAB3IP Antibody [H00117177-B01P] - Analysis of RAB3IP expression in human placenta.
Western Blot: RAB3IP Antibody [H00117177-B01P] - Analysis of RAB3IP expression in transfected 293T cell line by RAB3IP polyclonal antibody. Lane 1: RAB3IP transfected lysate(50.6 KDa). Lane 2: Non-transfected lysate.
Whole 3-5dpf fish was fixed at 4⁰C for 4 hours with 4% PFA, 4% sucrose and 0.01% Tween 20 in PBS and then rinsed twice with PBSDT. Primary antibody was diluted in PBSDT containing 3% BSA and 6% FBS at 1:200 dilution and samples incubated overnight with rocking at 4⁰C. After several washes larvae were incubated with AlexaFluor 594-mouse conjugated antibody and AlexaFluor 488-phalloidin
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.